Post by
Joemare on Apr 04, 2023 10:58am
Published Febraury 2023 - can this help TH's case?
Proteomic Analysis of Hepatic Fibrosis in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease Demonstrates Up-regulation of Immune Response and Tissue Repair Pathways
J Infect Dis 2023 Feb 14;227(4):565-576. doi: 10.1093/infdis/jiac475
Comment by
Joemare on Apr 04, 2023 11:05am
Authors...... Lindsay T Fourman 1, Takara L Stanley 1, Mollie W Ockene 1, Colin M McClure 1, Mabel Toribio 1, Kathleen E Corey 2, Raymond T Chung 2, Martin Torriani 3, David E Kleiner 4, Colleen M Hadigan 5, Steven K Grinspoon
Comment by
Wino115 on Apr 04, 2023 2:30pm
It's the Grinspoon lab team, they continue to reserach EGRIFTA and NASH/NAFLD for both HIV and non-HIV. It just adds more scientific data and possibly could be used by the MSLs in talking about the drug to clinics. It may add a bit more rationale if someone with HIV is starting to show NASH symptoms.
Comment by
scarlet1967 on Apr 04, 2023 3:33pm
https://stockhouse.com/companies/bullboard/t.th/theratechnologies-inc?postid=35199516